Ascendis Pharma A/S (NASDAQ:ASND) Downgraded by Bank of America Co. to Neutral

Ascendis Pharma A/S} stock has undergone multiple analysts rating changes in the recent past.  Ascendis Pharma A/S Downgraded by Bank of America Co. on 10/20/2021. In a note to investors, the firm issued a new rating of Neutral. The analysts previously had rating of Buy.

View More Ascendis Pharma A/S (NASDAQ:ASND) Downgraded by Bank of America Co. to Neutral